{"TopicDetails": {"type": 0, "ccm2Id": 47032588, "cftId": 0, "identifier": "HORIZON-JU-IHI-2024-08-01-two-stage", "title": "A city-based approach to reducing cardiovascular mortality in Europe", "publicationDateLong": 1719273600000, "callIdentifier": "HORIZON-JU-IHI-2024-08-two-stage", "callTitle": "Innovative Health Initiative JU Call 8", "callccm2Id": 47032605, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43108390, "abbreviation": "HORIZON", "description": "Horizon Europe Framework Programme (HORIZON)"}, "programmeDivision": [{"id": 45177852, "abbreviation": "HORIZON.2.1.7", "description": "Innovative Health Initiative"}, {"id": 43108557, "abbreviation": "HORIZON.2.1", "description": "Health"}, {"id": 43108541, "abbreviation": "HORIZON.2", "description": "Global Challenges and European Industrial Competitiveness"}], "topicMGAs": [], "tags": ["IHI JU", "IHI", "Innovative Health Initiative", "A city-based approach to reducing cardiovascular mortality in Europe", "Innovative Health Initiative Joint Undertaking", "Joint Undertaking"], "keywords": ["Health outcomes", "Cardiovascular diseases", "Healthcare system", "Clinical management", "Public Private Partnerships (PPP)", "Patient care"], "sme": false, "actions": [{"status": {"id": 31094502, "abbreviation": "Open", "description": "Open"}, "types": [{"typeOfAction": "HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "typeOfMGA": [{"id": 43027846, "abbreviation": "HORIZON-AG", "description": "HORIZON Action Grant Budget-Based"}]}], "plannedOpeningDate": "25 June 2024", "submissionProcedure": {"id": 31094505, "abbreviation": "two-stage", "description": "two-stage"}, "deadlineDates": ["10 October 2024", "23 April 2025"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3543165": [{"action": "HORIZON-JU-IHI-2024-08-02-two-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "25 June 2024", "deadlineModel": "two-stage", "deadlineDates": ["10 October 2024", "23 April 2025"], "budgetYearMap": {"2024": 47550000}, "expectedGrants": 1, "minContribution": 14000000, "maxContribution": 14000000, "budgetTopicActionMap": {}}, {"action": "HORIZON-JU-IHI-2024-08-04-two-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "25 June 2024", "deadlineModel": "two-stage", "deadlineDates": ["10 October 2024", "23 April 2025"], "budgetYearMap": {"2024": 47550000}, "expectedGrants": 1, "minContribution": 12600000, "maxContribution": 12600000, "budgetTopicActionMap": {}}, {"action": "HORIZON-JU-IHI-2024-08-03-two-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "25 June 2024", "deadlineModel": "two-stage", "deadlineDates": ["10 October 2024", "23 April 2025"], "budgetYearMap": {"2024": 47550000}, "expectedGrants": 1, "minContribution": 5200000, "maxContribution": 5200000, "budgetTopicActionMap": {}}, {"action": "HORIZON-JU-IHI-2024-08-01-two-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "25 June 2024", "deadlineModel": "two-stage", "deadlineDates": ["10 October 2024", "23 April 2025"], "budgetYearMap": {"2024": 47550000}, "expectedGrants": 1, "minContribution": 15750000, "maxContribution": 15750000, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2024"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<p>The action under this topic must contribute to all the following outcomes:</p><ul level=\"0\"><li><strong>patients and citizens </strong>will benefit from better preventive measures, earlier detection and diagnosis, better outcomes for disease management, and access to innovative and effective treatments for cardiovascular disease (CVD), as needed;</li><li><strong>healthcare providers </strong>will benefit from updated, evidence-based guidelines on CVD management and more efficient clinical pathways. They will also gain clarity on best practice examples in health management and CVD prevention means in European cities;</li><li><strong>healthcare system decision-makers</strong> will have better evidence and tools to implement appropriate CVD prevention strategies, including digital therapies, allowing for their introduction into clinical practice and adoption by all segments of society;</li><li><strong>health technology assessment bodies, payers and regulators </strong>will benefit from better information on the real-life use of cardiovascular medicinal products, the benefit-risk profile of medical devices and the value of CVD prevention in cities / urban areas (note: a city / urban area is expected to have a population of at least 50 000 in its urban centre, in line with the OECD-EC (Organisation for Economic Co-operation and Development \u2013 European Commission) definition of a city<strong><sup>1, 2</sup></strong>;</li><li><strong>researchers, including industry stakeholders, and clinical investigators</strong> will benefit from models and findings that will help future programme implementation in other cities in Europe and beyond.</li> </ul><p><sub><strong><sup>1 </sup></strong>OECD-EC, \u201c<a href=\"http://chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://ec.europa.eu/regional_policy/sources/focus/2012_01_city.pdf\">Cities in Europe: The new OECD-EC definition</a>\u201d January 2012.</sub></p><p><sub><strong><sup>2</sup></strong> European Commission, \u201c<a href=\"http://knowledge4policy.ec.europa.eu/foresight/topic/continuing-urbanisation/urbanisation-europe_en\">Urbanisation in Europe</a>\u201d last updated July 2020.</sub></p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>Cardiovascular diseases (CVD), the world's leading cause of mortality, are responsible for over 18 million deaths annually with a staggering cost of EUR 282 billion in 2021 <a href=\"http://pubmed.ncbi.nlm.nih.gov/30955367/\"><strong>[1]</strong></a>. The CVD risk has been acknowledged by WHO\u2019s Sustainable Development Goal (SDG) 3.4 which aims to reduce heart disease rates by one-third by 2030<sup><strong>1</strong></sup>. Trends in the EU27 and the UK from 1961 to 2018 show a decline in the share of the total population living in rural areas, while towns and cities experienced a smooth and constant population increase. Europe's level of urbanisation was 75% in 2022<sup><strong>2</strong></sup> and is expected to increase to approximately 83.7% in 2050<sup><strong>3</strong></sup>. In cities, CVD risks are amplified by factors like pollution, scarcity of green spaces and stressful lifestyles. The trend towards urbanisation often leads to significant healthcare disparities and worsening of CVD outcomes especially among underserved and disadvantaged communities. Thus, an improvement of the management of CVD in cities would be of significant benefit for the great majority of the European citizens living in an urban context.</p><p>The focus of this topic is on identifying and creating scalable models, interventions, and practices to enhance the overall efficiency and effectiveness of CVD management based on existing (e.g. <a href=\"http://www.novartisfoundation.org/transforming-population-health/cardio4cities\">Cardio4Cities</a>) <strong><a href=\"http://pubmed.ncbi.nlm.nih.gov/37040342/\">[2]</a> </strong>or new pilots in up to 5 cities, to build evidence for replication across Europe in different socio-economic conditions. These pilots should propose a good coverage of different locations and contexts in Europe and deliver scalable solutions that can be applied to other cities.</p><p>The action funded under this topic will consider primary and secondary prevention strategies, early detection, timely diagnosis and treatment (healthcare delivery), lifestyle changes (personal responsibility), and living environment (community responsibility).</p><p>Against this objective, the future action is expected to deliver:</p><ul level=\"0\"><li>predictive models (developed and validated) that integrate various data sources \u2013 including electronic health records, environmental data, and lifestyle factors \u2013 to forecast cardiovascular risk at the individual and population levels in urban settings;</li><li>models and/or good practices (including governance structure, funding/financing models, etc.) and roadmaps on cost-effective approaches to improve cardiovascular (CV) health management that can be replicated across Europe;</li><li>recommendations for updating European guidelines and standards on CVD management (including primary and secondary prevention, and treatment);</li><li>a stronger definition and improved selection of performance indicators on CV mortality, patient outcomes and economic impact of interventions;</li><li>harmonised data standards for measurement of performance and impact (including PROMs<sup><strong>4</strong></sup>, PREMs<sup><strong>5</strong></sup>, patient preference, clinical outcome assessments etc.).</li><li>an easy-to-use digital platform (ideally based on existing solutions to ensure interoperability) and high-quality data that enable a data-driven approach to CVD risk management, using standardised data reporting to facilitate comparison across cities;</li><li>new solutions: digital and telehealth for early detection and monitoring of CVD patients, leveraging technologies for monitoring by incorporating wearables and apps to continuously monitor the population's adherence to cardiovascular medications and the occurrence of potential side effects. Moreover, this will enhance predictive models with more granular data leading to more precise risk assessments;</li><li>recommendations on enhancing patient use of and access to technology and digital interventions (telemedicine, wearables, clinical mobile apps\u2026); targeted prevention strategies, urban planning recommendations, and public health policies to mitigate these risks;</li><li>a platform, network, or another support mechanism for exchange of good practice, learnings, and experience, to support further deployment of successful approaches across Europe and beyond;</li><li>recommendations on improving living conditions to support the goal of decreasing impact of cardiovascular diseases.</li> </ul><p>To address this challenge, the action funded under this topic should:</p><ul level=\"0\"><li>select up to five cities to serve as pilot use cases. These cities should be representative of the European context (in particular in relation to size and population) to allow broader implementation across regions/countries, different cultural and/or economic distributions, considering different health care structures (private/public) in different countries. Indicatively, each pilot city (or another urban administrative entity) is expected to have a population of at least 50 000 in its urban centre, in line with the OECD-EC definition of a city;</li><li>conduct a gap analysis of existing cardiovascular disease screening and diagnostics, clinical pathways and public health policies to guide the development of scalable models and best practices to fill these gaps, also considering broader European application (for example, set targets, define actions, strengthen enablers). In this analysis, due attention should be given to high-stress lifestyles (nutrition, physical activity) and socio-economic disparities. The identified solutions for improvement should be based on data-driven insights to identify multi-sectorial interventions that improve the management of CVD risk factors (such as hypertension, diabetes, low-density lipoprotein cholesterol) and prevent these risks from developing. They should also consider the entire continuum of care (detect, treat, control). The work on performance indicators including harmonisation is key to set a baseline from which improvements can be made. Applicants are expected to consider all applicable legislative and regulatory constraints (national, regional, local) and their possible impact on the implementation and results of the project. End-users (including citizens, patients, healthcare professionals and providers, health technology developers among others) should be included from the start in the co-creation process to ensure future buy-in and implementation.</li><li>collaborate with patients and citizens to develop strategies and guidance for effective CV health awareness campaigns;</li><li>collaborate with healthcare professionals to review and adapt guidance on CVD prevention and management, identifying opportunities to maintain and optimise healthcare workforce resources and engagement;</li><li>set up sustainable platforms and other support mechanisms for deployment of the models (sharing best practice between pilot cities and across regions);</li><li>pilot novel and/or improved early detection and diagnostic solutions, patient management strategies, (including improved patient support, remote patient management, patient flows), and initiatives to maintain workforce engagement;</li><li>explore potential funding tools to complement healthcare systems funding for managing cardiovascular health (including bonds, insurance, crowdsourcing, etc.) which could be used to implement the models;</li><li>leverage existing and newly created sources of multimodal data (contemplating opportunities provided by EHDS) for decision making and management of CVD (collecting, connecting, standardising, processing and analysing);</li><li>design and deploy communication<strong> </strong>and awareness-raising campaigns, including training and capacity-building for health workers to effectively address various population groups affected by CVD.</li> </ul><p>Applicants should consider synergies with relevant initiatives at national level and with other European health initiatives such as the European Innovation Partnership on Active and Healthy Ageing<sup><strong>6</strong></sup>, Reference Site Collaboration Network<sup><strong>7</strong></sup>, Urban Health Cluster<sup><strong>8</strong></sup>, the Cities and Cancer Missions<sup><strong>9</strong></sup> and the Joint Action on Cardiovascular Diseases and Diabetes (JACARDI) funded by the EU4Health programme, to maximise the potential for creating models that can be applied in various urban settings to improve cardiovascular health. This collaborative approach underscores the potential for cross-applicability of health solutions in addressing chronic diseases.</p><p>The action should also consider learnings and synergies with other IMI and IHI initiatives such as H2O, EHDEN, BigData@Heart, iCARE4CVD, among others.</p><p>Applicants are expected to consider the potential regulatory impact of the results and \u2013 as relevant \u2013 develop a regulatory strategy and interaction plan for generating appropriate evidence as well as engaging with regulators in a timely manner (e.g. national competent authorities, EMA Innovation Task Force, qualification advice).</p><p><sub><strong><sup>1 </sup></strong>WHO, \u201c<a href=\"http://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases#:~:text=NCDs%20threaten%20progress%20towards%20the,is%20closely%20linked%20with%20NCDs.\">Noncommunicable diseases (who.int)</a>\u201d September 2023.</sub></p><p><sub><sup><strong>2</strong></sup> <a href=\"http://data.worldbank.org/&#xa0;\">https://data.worldbank.org/ </a></sub></p><p><sub><strong><sup>3</sup> </strong>European Commission, \u201c<a href=\"http://knowledge4policy.ec.europa.eu/foresight/topic/continuing-urbanisation/urbanisation-europe_en\">Urbanisation in Europe</a>\u201d last updated July 2020.</sub></p><p><sub><sup><strong>4</strong></sup> PROM: Patient Reported Outcome Measurements</sub></p><p><sub><sup><strong>5</strong></sup> PREM: Patient Reported Experience Measurements</sub></p><p><sub><sup><strong>6 </strong></sup>European Commission, \u201c<a href=\"http://digital-strategy.ec.europa.eu/en/policies/eip-aha\">The European Innovation Partnership on Active and Healthy Ageing (EIP on AHA)</a>\u201d Accessed March 2024.</sub></p><p><sub><strong><sup>7</sup> </strong>Reference Site Collaboration Network, \u201c<a href=\"http://www.rscn.eu/\">Home - RSCN</a>\u201d Accessed March 2024.</sub></p><p><sub><sup><strong>8 </strong></sup>Urban Health Cluster, \u201c<a href=\"http://www.urban-health.eu/\">Urban Health Cluster | The first European Cluster to improve and safeguard health and well-being of citizens, leaving none behind</a>\u201d Accessed March 2024.</sub></p><p><sub><strong><sup>9</sup> </strong>European Commission, \u201c<a href=\"http://research-and-innovation.ec.europa.eu/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-europe/eu-missions-horizon-europe_en\">EU Missions in Horizon Europe</a>\u201d Accessed May 2024.</sub></p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>The action under this topic is expected to achieve all the following impacts and contribute to the following EU policies/initiatives:</p><ul level=\"0\"><li>decrease the CVD burden in European cities by the reduction of CV events, disability, and mortality;</li><li>enable future clinical pathways leading to improved patient outcomes;</li><li>reduce the pressure of patient flow in the healthcare system via innovative diagnostic/detection solutions;</li><li>strengthen the definition, standardisation and selection of performance indicators on CVD mortality, patient outcomes and economic impact of interventions, and thus improve future clinical pathways and intervention implementation studies;</li><li>optimise healthcare expenditure to tackle the financial strain of CVD, amounting to \u20ac282 billion annually in the EU <a href=\"http://pubmed.ncbi.nlm.nih.gov/37632363/\"><strong>[1]</strong></a>. The emphasis is on prioritising spending for maximum efficiency and value, balancing the costs of advanced interventions with their long-term benefits;</li><li>strengthen public awareness initiatives and incorporate improved diagnostic methods to enhance early detection and treatment of CVD, to reduce premature CVD deaths and support preventive healthcare measures;</li><li>strengthen patient and citizen input to treatment pathways, disease monitoring and scientific guideline enhancement;</li><li>contribute to the European policy on Active and Healthy Aging , and to the implementation of the European Commission\u2019s proposal for the European Health Data Space (EHDS) by providing FAIR data that are aligned with the EHDS requirements;</li><li>start building a system for continual impact assessment and provide early evidence on the impact and effectiveness of the applied recommendations.</li> </ul><p>These impacts are in alignment with specific objectives 3 and 2 of IHI JU<sup><strong>1</strong></sup>.</p><p><sub><sup><strong>1</strong></sup> <a href=\"http://www.ihi.europa.eu/sites/default/files/flmngr/IHI_Strategic_Research_and_Innovation_Agenda_3.pdf\">https://www.ihi.europa.eu/sites/default/files/flmngr/IHI_Strategic_Research_and_Innovation_Agenda_3.pdf</a></sub></p>\n", "conditions": "<h1><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: medium;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\">General conditions</span></b></span></span></span></h1>\r\n<p class=\"MsoNormal\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">1. Admissibility conditions: </span></b><span lang=\"EN-US\">described in </span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex A</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">and </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex E</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Horizon Europe Work Programme General Annexes</span></span></span></p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\n<p style=\"margin-left: 40px;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\"> described in Part B of the Application Form available in the Submission System</span></span></span></span></p>\r\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">at      stage 1 of a two-stage Call, the limit for RIA short proposals is 20      pages;</li>\r\n</ul>\r\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">at      stage 2 of a two-stage Call, the limit for RIA full proposals is 50 pages.<b><o:p></o:p></b></li>\r\n</ul>\r\n<p>&nbsp;</p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">2. Eligible countries: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;&#10;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex B</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">of the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-left: 40px;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Horizon Europe Programme Guide</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">.</span></span></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\"> described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex B</span></span></a></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"> <span lang=\"EN-US\">of the Work Programme General Annexes&nbsp;</span></span></span></span><font face=\"Arial\" size=\"2\">and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024_Amend1.pdf\" target=\"_blank\">IHI JU Work Programme (WP)</a></font></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b>4. Financial and operational capacity and exclusion: </b>described in </span></span></span><span style=\"mso-bidi-font-weight:bold\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex C</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"> of the Work Programme General Annexes</span></span></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></span></span></span></p>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Award criteria, scoring and      thresholds</span></b><span lang=\"EN-US\"> are      described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      D</span></span></a></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">of      the Work Programme General Annexes&nbsp;</span></span></span></span><font face=\"Arial\" size=\"2\"><span lang=\"EN-US\"><o:p></o:p></span>and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024_Amend1.pdf\" target=\"_blank\">IHI JU Work Programme (WP)</a></font></p>\r\n    </li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Submission and evaluation      processes</span></b><span lang=\"EN-US\"> are      described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      F</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of      the Work Programme General Annexes and the </span></span></span></span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Online      Manual</span></span></a><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n    </li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Indicative timeline for      evaluation and grant agreement: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      F</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n    </li>\r\n</ul>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\">6. Legal and financial set-up of the grants: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex G</span></span></a></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Work Programme General Annexes</span></span></span></span></p>\r\n<p>&nbsp;</p>\n<h1><span style=\"font-size: medium;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\">Specific conditions</span></b></span></span><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\"><o:p></o:p></span></b></h1>\r\n<p class=\"MsoNormal\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">7. Specific conditions: </span></b><span lang=\"EN-US\">described in the&nbsp;</span></span></span></span><font face=\"Arial\" size=\"2\">''Conditions of the Calls for proposals and Calls management rules'' section of the <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024_Amend1.pdf\" target=\"_blank\">IHI JU Work Programme (WP)</a></font></p>\r\n<ul>\r\n    <li>specific conditions on Availability, Accessibility and Affordability (3A) <strong>do not apply to this topic</strong></li>\r\n    <li>JU's right to object to transfer/exclusive licensing</li>\r\n</ul>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\"><o:p></o:p></span></p>\n<h1><span style=\"font-size: medium;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\"><span style=\"font-family: Arial;\">Documents</span></span></b></span><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\"><o:p></o:p></span></b></h1>\r\n<div><b>Where relevant, templates of the reference documents and associated guidance can be found on <a href=\"https://www.ihi.europa.eu/apply-funding/call-documents\">the&nbsp;IHI JU&nbsp;website</a>.</b></div>\r\n<p class=\"MsoNormal\"><b>Regarding the application forms for submitting proposals, the relevant templates and annexes are available to download in the submission system.</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">&nbsp;<span lang=\"EN-US\">The IHI JU 8</span><sup>th</sup>&nbsp;<span lang=\"EN-US\">Call for proposals full topics text is available <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Call8_CallText.pdf\">here</a>.</span></p>\r\n<p class=\"MsoNormal\"><b>Evaluation form (single and two-stage Calls)</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Evaluation_form_RIA_UpdateDec2023.pdf\">IHI JU Evaluation form for Research and Innovation Actions&nbsp;</a>(single and two-stage Calls)<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">Proposal Templates Part A and Part B (Research and Innovation Actions &ndash; single-stage and second stage of two-stage procedure)&nbsp;</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;&nbsp;<b><span lang=\"EN-IE\">Proposal template - Part A</span></b><span lang=\"EN-IE\">&nbsp;of the proposal is generated by the IT system in the submission environment (for more information see the HE Part A template&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-ria-ia_en.pdf\"><span lang=\"EN-IE\">here</span></a><span lang=\"EN-IE\">). In Part A of the proposal applicants insert general information on their proposal (e.g. proposal acronym), details on the participants and the overall proposal budget. <br />\r\nPlease note that&nbsp;<strong>only&nbsp;</strong>Part A of this template is applicable for this call. For Part B, see point below.</span><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><span lang=\"FR-BE\">- <a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Proposal_template_RIA_SP_PartB.pdf\">IHI JU Proposal template (RIA/SP) &ndash; Part B</a>&nbsp;&nbsp;<o:p></o:p></span><b><u><span lang=\"EN-IE\">(applicable to the first-stage of two-stage Calls)</span></u></b></p>\r\n<p class=\"MsoNormal\">-&nbsp;<span lang=\"EN-IE\"><a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Proposal_template_RIA_FP_PartB_UpdateJune2024.pdf\" target=\"_blank\">IHI JU Proposal template (RIA/FP) - Part B</a></span>&nbsp;<b><u><span lang=\"EN-IE\">(applicable to the second stage of two-stage Calls)</span></u></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b>Proposal Annexes</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b>- Annex: Type of Participants</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The&nbsp;<i>&ldquo;type of participants&rdquo;</i>&nbsp;is an IHI specific annex.<o:p></o:p></p>\r\n<p class=\"MsoNormal\">The excel template for:<o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;short proposals (first stage of two-stage calls) can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Annex_Type_of_participants_Stage1.xlsx\">here</a>&nbsp;and<o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;full proposals (single-stage calls, and second stage of two-stage calls) can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_Type_of_participants.xlsx\">here</a>&nbsp;<o:p></o:p></p>\r\n<p class=\"MsoNormal\">The instructions on how to fill in this template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_Type_of_participants_instrucctions.pdf\">here</a>.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a compulsory annex, and it must be uploaded as a separate document in the submission system.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\">This annex is applicable to single-stage and in both stages of two-stage Calls.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">- Annex: Declaration of in-kind contribution commitment</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The &ldquo;<i>Declaration of in-kind contribution commitment&rdquo;</i>&nbsp;is an IHI specific annex and it is applicable to the single stage and second stage of two-stage Calls.<o:p></o:p></p>\r\n<p class=\"MsoNormal\">The word document template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_declaration_in_kind_contribution_commitment%20.pdf\">here</a>.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a is a compulsory annex and it must be uploaded as a separate document in the submission system.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">- Annex: In-kind contributions to additional activities (IKAA)</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The &lsquo;<i>&rsquo;In-kind contributions to additional activities (IKAA)&rsquo;&rsquo;</i>&nbsp;is an IHI specific annex. The excel template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Annex_declaration_in_kind_contribution_additional_activities_UpdateDec2023.xlsx\">here</a>&nbsp;and the instructions on how to fill in this template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_declaration_in_kind_contribution_additional_activities_instructions.pdf\">here</a>.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is an optional annex and&nbsp;it is applicable to the single stage and second stage of two-stage Calls.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">- Annex: Essential information for clinical studies</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The information on clinical studies is a Horizon Europe annex.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a is a compulsory annex and it must be uploaded as a separate document in the submission system.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\">If your proposal does not include clinical studies,&nbsp;<u>please upload a statement declaring your proposal does not include clinical studies.</u><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The information on clinical studies annex can be found&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx\">here</a>:<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>The annex&nbsp;is applicable to the single stage and second stage of two-stage Calls</i><i><span lang=\"EN-IE\">.</span></i><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">- Annex: Ethics</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">This is a HE annex. Ethics self-assessment should be included in proposal part A. However, in Calls where several serious ethics issues are expected, the characters limit in this section of proposal part A may not be sufficient for participants to give all necessary information. In those cases, participants may include additional information in an annex to proposal part B.&nbsp;<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is an optional annex and&nbsp;it is applicable to the single stage and second stage of two-stage Calls.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">- Annex to the budget for the Full Proposal&nbsp;</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a compulsory&nbsp;</i><i><a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/Annex_Budget_for_full_Proposal_TWO_stage_call_UpdateJun2024.xlsx\" target=\"_blank\">Annex</a></i><u>,</u>&nbsp;which complements the budget figures already included in the proposal budget in PART A. Its purpose is to correctly guide the consortium in providing IHI-specific budget items (e.g. IKOP, IKAA, FC PAID, FC RECEIVED, etc.) and to comply with IHI additional eligibility criteria (e.g. 45% industry contribution).<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>The annex is applicable to the</i>&nbsp;<i>single stage and second stage of two-stage Calls</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\">&nbsp;&nbsp;<b>Model Grant Agreement (MGA)</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\">&nbsp;-&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf\">HE&nbsp;General MGA v1.0</a><o:p></o:p></p>\n<h2><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Additional documents:</span></b></span></span></span></h2>\r\n<h2><b><span lang=\"EN-US\"><o:p></o:p></span></b></h2>\r\n<p class=\"MsoNormal\"><b>-&nbsp;<a href=\"https://eur-lex.europa.eu/eli/reg/2021/2085\">Council Regulation (EU) 2021/2085 of 19 November 2021 establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014</a>&nbsp;&nbsp;(in short Single Basic Act &lsquo;SBA&rsquo; or Council Regulation (EU) 2021/2085).</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">- <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024_Amend1.pdf\">IHI JU Work Programme (WP)</a><b><o:p></o:p></b></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/flmngr/IHI_Strategic_Research_and_Innovation_Agenda_3.pdf\">Strategic Research and Innovation Agenda (SRIA)</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Guide_for_Applicants.pdf\" target=\"_blank\">IHI JU Guide for Applicants</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/Call_FAQs.pdf\" target=\"_blank\">IHI&nbsp;JU&nbsp;FAQs</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b>Horizon Europe Reference Documents</b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-1-general-introduction_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 1. General Introduction</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-2-msca-actions_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 2. Marie Sk\u0142odowska-Curie Actions</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-3-research-infrastructures_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 3. Research Infrastructures</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-4-health_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 4. Health</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-5-culture-creativity-and-inclusive-society_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 5. Culture, creativity and inclusive society</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-6-civil-security-for-society_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 6. Civil Security for Society</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-7-digital-industry-and-space_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 7. Digital, Industry and Space</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-8-climate-energy-and-mobility_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 8. Climate, Energy and Mobility</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-9-food-bioeconomy-natural-resources-agriculture-and-environment_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 9. Food, Bioeconomy, Natural Resources, Agriculture and Environment</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-10-european-innovation-ecosystems_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 10. European Innovation Ecosystems (EIE)</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-11-widening-participation-and-strengthening-the-european-research-area_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 11. Widening participation and strengthening the European Research Area</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-12-missions_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 12. Missions</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 13. General Annexes</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Programme Guide</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0695\" target=\"_blank\" style=\"font-family: Arial;\"><span style=\"font-size: small;\">HE Framework Programme and Rules for Participation Regulation 2021/695</span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021D0764\" target=\"_blank\"><span style=\"font-size: small;\">HE Specific Programme Decision 2021/764</span></a></span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">EU Financial Regulation</span></span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/rules-lev-lear-fca_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/aga_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">EU Grants AGA </span>&mdash; Annotated Model Grant Agreement</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">Funding &amp; Tenders Portal Online Manual</span></span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/tc_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Funding &amp; Tenders Portal Terms and Conditions</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/privacy-statement_en.pdf\" style=\"font-size: 11pt; font-family: Arial;\"><span style=\"font-size: small;\">Funding &amp; Tenders Portal Privacy Statement</span></a></p>", "supportInfo": "<p class=\"MsoNormal\">Please read carefully all provisions below before the preparation of your application.</p>\r\n<p class=\"MsoNormal\">All the information concerning the IHI JU Calls is also published on the&nbsp;<a href=\"https://www.ihi.europa.eu/apply-funding/call-documents\" target=\"_blank\">IHI JU website</a>.&nbsp;&nbsp;&nbsp;<o:p></o:p></p>\r\n<p class=\"MsoNormal\">All the questions pertaining to the IHI JU Calls are to be addressed to&nbsp;<a href=\"mailto:infodesk@ihi.europa.eu\">infodesk@ihi.europa.eu</a>.<o:p></o:p></p>\r\n<p><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;font-weight:normal;mso-bidi-font-weight:bold\"><b><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\" target=\"_blank\">Online Manual</a>&nbsp;</b></span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">is your guide on the procedures from proposal submission to managing your grant.<o:p></o:p></span></p>\r\n<p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Horizon Europe Programme Guide</span></b></a><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;</span></strong><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif; font-weight: normal;\">contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;type=undefined;categories=;programme=H2020;actions=;keyword=\" target=\"_blank\">Funding &amp; Tenders Portal FAQ</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/research-and-innovation/contact/research-enquiry-service_en\" target=\"_blank\">Research Enquiry Service</a></span>&nbsp;</b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</span></p>\r\n<p><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/ncp\" target=\"_blank\">National Contact Points (NCPs)</a>&nbsp;</span></b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (&lsquo;third-countries&rsquo;).<b><o:p></o:p></b></span></p>\r\n<p><a href=\"https://een.ec.europa.eu/\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Enterprise Europe Network</span></b></a><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;color:#003366\">&nbsp;</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" target=\"_blank\">IT Helpdesk</a></span></b>&nbsp;</span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash;&nbsp;contact the Funding &amp; Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://www.iprhelpdesk.eu/\" target=\"_blank\">European IPR Helpdesk</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;assists you on intellectual property issues.<br />\r\n<br />\r\n</span><b><a href=\"mailto:research@cencenelec.eu\" target=\"_blank\">CEN-CENELEC Research Helpdesk</a> and <a href=\"https://www.etsi.org/research/helpdesk\" target=\"_blank\">ETSI Research Helpdesk</a></b>&nbsp;<span style=\"font-family: Arial, sans-serif;\">&ndash;&nbsp;</span>the European Standards Organisations&nbsp;advise you how to tackle standardisation in your project proposal.&nbsp;&nbsp;</p>\r\n<p class=\"MsoNormal\" style=\"margin-left:36.0pt\"><o:p></o:p></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://euraxess.ec.europa.eu/sites/default/files/am509774cee_en_e4.pdf\" target=\"_blank\">The European Charter for Researchers and the Code of Conduct for their recruitment</a></span></b></span><span style=\"font-size:&#10;9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366\"> </span><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366;font-weight:&#10;normal;mso-bidi-font-weight:bold\">&ndash; consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.</span></strong><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></b></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/partner-search\" target=\"_blank\">Partner Search Services</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;help you find a partner organisation for your proposal.<o:p></o:p></span></p>\r\n<p>&nbsp;</p>", "sepTemplate": "<p>The submission system is planned to be opened on the date stated on the topic header.</p>\r\n<p>\r\n<p class=\"MsoNormal\">To access the Electronic Submission Service, please click on the submission-button next to the&nbsp;<b>type of action</b>&nbsp;and the&nbsp;<b>type of model grant agreement</b>&nbsp;that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.<o:p></o:p></p>\r\n<p class=\"MsoNormal\">To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.<o:p></o:p></p>\r\n</p>", "links": [{"callIdentifier": "HORIZON-JU-IHI-2024-08-two-stage", "status": "Open", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "HORIZON-JU-RIA", "criterionDescription": "HORIZON JU Research and Innovation Actions", "url": "https://ec.europa.eu/research/participants/submission/manage/screen/submission/create-draft/36939?topic=HORIZON-JU-IHI-2024-08-01-two-stage", "startDate": "Jun 25, 2024 12:00:00 AM", "endDate": "Oct 10, 2024 5:00:00 PM", "mgaDescription": "HORIZON Action Grant Budget-Based", "mgaCode": "HORIZON-AG"}], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Jun 25, 2024 12:00:01 AM", "lastChangeDate": "Jun 25, 2024 12:00:01 AM", "content": "The submission session is now available for: HORIZON-JU-IHI-2024-08-03-two-stage(HORIZON-JU-RIA), HORIZON-JU-IHI-2024-08-01-two-stage(HORIZON-JU-RIA), HORIZON-JU-IHI-2024-08-02-two-stage(HORIZON-JU-RIA), HORIZON-JU-IHI-2024-08-04-two-stage(HORIZON-JU-RIA)"}], "hasForthcomingTopics": false, "hasOpenTopics": true, "allClosedTopics": false}}}